drug · small molecule
patient view →TP-04
Phase 2updated 2mo agoby $TARS Tarsus Pharmaceuticals, Inc.🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for nasopharyngeal carcinoma and eye infection and 2 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that